Catalent to expand manufacturing for Covid-19 vaccine candidate AZD1222
The manufacturing of the AZD1222 vaccine candidate will be taken up at Catalent’s commercial gene therapy manufacturing plant in Harmans, Maryland. Catalent said that it will prepare the